Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 605-620-0 | CAS number: 171869-89-9
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
No studies are available. Based on the molecular structure, molecular weight, water solubility, and octanol-water partition coefficient it can be expected that 1,2-ethanediamine, N1-[3-(trimethoxysilyl)propyl]-, N-[(ethenylphenyl)methyl] derivs., hydrochlorides is likely to be absorbed via the oral and inhalation route. Dermal absorption is considered to be very low. Hydrolysis occurs rapidly, and exposure is expected to both the parent substance 1,2-ethanediamine, N1-[3-(trimethoxysilyl)propyl]-, N-[(ethenylphenyl)methyl] derivs., hydrochlorides and its hydrolysis products. Based on their physico-chemical parameters, the registration substance and its silicon-containing hydrolysis products are likely to be well distributed in the body barring one constituent and its silicon-containing hydrolysis product and excretion via urine and feces can be expected. The bioaccumulation potential is expected to be low.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
Additional information
No studies are available. Based on the molecular structure, molecular weight, water solubility, and octanol-water partition coefficient it can be expected that 1,2-ethanediamine, N1-[3-(trimethoxysilyl)propyl]-, N-[(ethenylphenyl)methyl] derivs., hydrochlorides is likely to be absorbed via the oral and inhalation route. Dermal absorption is considered to be very low. Hydrolysis occurs rapidly, and exposure is expected to both the parent substance 1,2-ethanediamine, N1-[3-(trimethoxysilyl)propyl]-, N-[(ethenylphenyl)methyl] derivs., hydrochlorides and its hydrolysis products. Based on their physico-chemical parameters, the registration substance and its silicon-containing hydrolysis products are likely to be well distributed in the body barring one constituent and its silicon-containing hydrolysis product and excretion via urine and feces can be expected. The bioaccumulation potential is expected to be low. The detailed toxicokinetic behaviour assessment of the substance and its hydrolysis products is attached in IUCLID Section 13.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
